Thiouracil can cause cancer according to The World Health Organization’s International Agency for Research on Cancer (IARC). Thiouracil is a nucleobase analogue that is uracil in which the oxo group at C-2 is replaced by a thioxo group. Among its listed roles, it functions as a antithyroid drug and a metabolite. It is a thiocarbonyl compound and a nucleobase analogue. Functionally, it is related to uracil. It is grouped under the following drug class(es): Thyroid agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Deracil, Antagothyroid, 2-thiouracil and Nobilen. Its PubChem CID is 1269845.
Thiouracil
| CAS No | 141-90-2 |
|---|---|
| Molecular Formula | C4H4N2OS |
| Molecular Weight | 128.15 g/mol |
| Synonyms | 2-sulfanylidene-1H-pyrimidin-4-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Thiouracil can cause cancer according to The World Health Organization's International Agency for Research on Cancer (IARC). Thiouracil is a nucleobase analogue that is uracil in which the oxo group at C-2 is replaced by a thioxo group.
The listed CAS number is 141-90-2.
The listed molecular formula is C4H4N2OS.
The listed molecular weight is 128.15 g/mol.
2-sulfanylidene-1H-pyrimidin-4-one.
The source lists Deracil, Antagothyroid, 2-thiouracil and Nobilen.